C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2720644
The present invention relates to the method of determining the risk of acute kidney injury comprising determining the amount of a marker selected from VCAN, NRP1, CCL2, CCL19, COL3A1, GZMM or any combination thereof in a sample.
La présente invention porte sur le procédé de détermination du risque de lésion rénale aiguë comprenant la détermination de la quantité d'un marqueur choisi parmi VCAN, NRP1, CCL2, CCL19, COL3A1, GZMM ou n'importe quelle combinaison de ceux-ci dans un échantillon.
Kainz Alexander
Mayer Bernd
Oberbauer Rainer
Perco Paul
Gowling Lafleur Henderson Llp
Oberbauer Rainer
LandOfFree
Markers of acute kidney failure does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Markers of acute kidney failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Markers of acute kidney failure will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1771822